Warby Parker Opens Preorders for AI Glasses; Core Thesis Unchanged

What happened

Warby Parker has begun taking preorders for its first Intelligent Eyewear collection, featuring three frames developed with Google and Samsung, priced from $395 with deliveries starting mid-December. The launch marks a concrete step in commercializing the AI-glasses partnership that management has been touting, but the announcement provides no unit economics, revenue expectations, or margin impact. The company's core optical retail business continues to face tariff headwinds and a mix shift toward lower-margin contacts and exams, while the stock trades at roughly 216x EV/EBITDA. Given that the preorder initiative is unlikely to be financially material in the near term, the market's reaction may hinge on sentiment rather than fundamentals. The master report's 'POTENTIAL SELL' rating remains appropriate as the valuation still prices in flawless execution and a substantial AI halo.

Implication

The preorder announcement is a positive signal for the AI-glasses thesis, but at $395, the product targets a different customer than Warby's core value offerings, and adoption is uncertain. Without disclosed unit projections or margin contributions, the financial impact is speculative, and the company's low double-digit EBITDA margins leave little room for error. The master report's base case already assumes continued revenue growth and margin expansion, so the stock's current price embeds high expectations for both the core business and the new hardware line. Any delay or underperformance in smart-glasses sales could trigger multiple compression, while the core business faces headwinds from tariffs and mix shift. Investors should wait for actual sales data and margin impact before considering any re-rating, and attractive entry remains near $18 per the master report.

Thesis delta

The master report's thesis was bearish due to extreme valuation and uncertain AI halo. This news confirms that the AI-glasses partnership is progressing, but it does not provide evidence of commercial success or material financial impact. Therefore, the thesis is unchanged: the stock remains overvalued relative to fundamentals, and the smart-glasses initiative remains an option that is not yet worth paying for.